PL1891962T3 - System dostarczania na bazie glutationu - Google Patents
System dostarczania na bazie glutationuInfo
- Publication number
- PL1891962T3 PL1891962T3 PL05292820T PL05292820T PL1891962T3 PL 1891962 T3 PL1891962 T3 PL 1891962T3 PL 05292820 T PL05292820 T PL 05292820T PL 05292820 T PL05292820 T PL 05292820T PL 1891962 T3 PL1891962 T3 PL 1891962T3
- Authority
- PL
- Poland
- Prior art keywords
- delivery system
- based delivery
- glutathione based
- glutathione
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/303,934 US7446096B2 (en) | 2005-12-19 | 2005-12-19 | Glutathione based delivery system |
| EP05292820.7A EP1891962B1 (en) | 2005-12-19 | 2005-12-29 | Glutathione based delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1891962T3 true PL1891962T3 (pl) | 2015-01-30 |
Family
ID=36217526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05292820T PL1891962T3 (pl) | 2005-12-19 | 2005-12-29 | System dostarczania na bazie glutationu |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US7446096B2 (pl) |
| EP (2) | EP2837384A1 (pl) |
| JP (2) | JP4773200B2 (pl) |
| CN (2) | CN101385859B (pl) |
| CY (1) | CY1115542T1 (pl) |
| DK (1) | DK1891962T3 (pl) |
| ES (1) | ES2516665T3 (pl) |
| PL (1) | PL1891962T3 (pl) |
| PT (1) | PT1891962E (pl) |
| SI (1) | SI1891962T1 (pl) |
| TW (1) | TWI365754B (pl) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| US20040057983A1 (en) | 2002-09-25 | 2004-03-25 | David Schmidt | Biomolecular wearable apparatus |
| JP4847437B2 (ja) * | 2004-03-03 | 2011-12-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | アルカロイド製剤 |
| RU2377019C2 (ru) * | 2004-08-03 | 2009-12-27 | Вайтал Хэлф Сайнсис Пти Лтд | Транспортирующий наполнитель для энтерального применения |
| US20090239827A1 (en) * | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
| MX2007015949A (es) | 2005-06-17 | 2008-03-07 | Vital Health Sciences Pty Ltd | Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos. |
| US7446096B2 (en) * | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
| US8067380B2 (en) * | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
| WO2008118013A2 (en) * | 2007-03-23 | 2008-10-02 | To-Bbb Holding B.V. | Targeted intracellular delivery of antiviral agents |
| FR2926725B1 (fr) * | 2008-01-25 | 2010-09-03 | Biochimie Appliquee Soc | Compositions cosmetiques et/ou dermatologiques cicatrisantes |
| US8602961B2 (en) | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
| KR101727333B1 (ko) * | 2008-11-26 | 2017-04-14 | 추가이 세이야쿠 가부시키가이샤 | 베시클 제제 |
| EP2368989A4 (en) | 2008-11-26 | 2012-09-26 | Chugai Pharmaceutical Co Ltd | OLOGORIBONUCLEOTIDE OR PEPTIDE NUCLEIC ACID CAPABLE OF INHIBITING HEPATITIS C VIRUS ACTIVITY |
| DK3395372T3 (da) * | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| RU2553350C2 (ru) | 2010-03-30 | 2015-06-10 | Фосфейдженикс Лимитед | Трансдермальные пластыри |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| GB201302427D0 (en) | 2013-02-12 | 2013-03-27 | Midatech Ltd | Nanoparticle delivery compositions |
| WO2015031673A2 (en) | 2013-08-28 | 2015-03-05 | Bioasis Technologies Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| RU2707285C2 (ru) | 2013-10-08 | 2019-11-26 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Рапамицин для лечения лимфангиолейомиоматоза |
| US10765755B1 (en) * | 2013-11-20 | 2020-09-08 | University Of South Florida | Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies |
| HRP20230863T1 (hr) | 2014-04-04 | 2023-11-10 | AI Therapeutics, Inc. | Inhalacijska formulacija rapamicina, namijenjena liječenju stanja povezanih sa starenjem |
| WO2015154897A1 (en) * | 2014-04-08 | 2015-10-15 | Wolfgang Stremmel | Means and methods for treating disorders of copper metabolism |
| US20170037184A1 (en) * | 2014-04-17 | 2017-02-09 | The Corporation Of Mercer University | Vitamin e-based nanocarriers for drug delivery and methods of making and using the same |
| EP3209330B1 (en) | 2014-10-07 | 2022-02-23 | AI Therapeutics, Inc. | An inhalable sirolimus formulation for the treatment of pulmonary hypertension |
| US10758520B1 (en) | 2015-05-20 | 2020-09-01 | University Of South Florida | Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier |
| EP3383371B1 (en) | 2015-12-09 | 2024-05-01 | Avecho Biotechnology Limited | Pharmaceutical formulation |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
| US10226442B2 (en) * | 2017-07-10 | 2019-03-12 | Syneurx International (Taiwan) Corp. | Lithium salts of N-substituted glycine compounds and uses thereof |
| US10842755B2 (en) | 2018-03-23 | 2020-11-24 | University Of South Carolina | Nanoparticles for brain targeted drug delivery |
| WO2021054927A2 (en) * | 2018-08-10 | 2021-03-25 | South Dakota Board Of Regents | Glutathione-cholesterol derivatives as brain targeting agents |
| KR102465308B1 (ko) * | 2019-05-28 | 2022-11-11 | 울산과학기술원 | 글루타치온-ｓ-전이효소 및 표적 세포 또는 표적 단백질 결합능을 갖는 단백질을 포함하는 리포좀 및 이의 용도 |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
| TW202228792A (zh) | 2020-10-09 | 2022-08-01 | 殷漢生技股份有限公司 | 吸入用奈米載體製劑 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142915A (ja) | 1983-12-28 | 1985-07-29 | Lion Corp | 口腔用組成物 |
| JPS632922A (ja) | 1986-06-20 | 1988-01-07 | Yamanouchi Pharmaceut Co Ltd | ドラツグキヤリア |
| JPH0714865B2 (ja) * | 1986-10-28 | 1995-02-22 | 武田薬品工業株式会社 | リポソ−ム製剤およびその製造法 |
| FR2627385B3 (fr) | 1988-02-23 | 1991-08-23 | Serobiologiques Lab Sa | Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques |
| US5695751A (en) | 1993-04-08 | 1997-12-09 | Cornell Research Foundation, Inc. | Enhancing delivery of large neutral amino acid drugs |
| JPH0834779A (ja) * | 1994-05-20 | 1996-02-06 | Senju Pharmaceut Co Ltd | トコフェロール誘導体 |
| US6653331B2 (en) | 1996-07-03 | 2003-11-25 | Pharmacia & Upjohn Company | Targeted drug delivery using sulfonamide derivatives |
| EP1017366A4 (en) * | 1996-09-01 | 2006-03-22 | Pharmos Corp | SOLID COPARCIPITATES FOR IMPROVED BIOVERABILITY OF LIPOPHILIC SUBSTANCES |
| AU4907897A (en) * | 1996-10-11 | 1998-05-11 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method |
| US6228347B1 (en) | 1997-12-01 | 2001-05-08 | Thione International, Inc. | Antioxidant gel for gingival conditions |
| KR20010042752A (ko) * | 1998-04-16 | 2001-05-25 | 야스이 쇼사꾸 | 글루타티온 유도체 및 이의 투여 형태 |
| JP2004323486A (ja) * | 2003-04-30 | 2004-11-18 | National Institute Of Advanced Industrial & Technology | 網膜及び／又はブドウ膜疾患の予防乃至治療用点眼薬 |
| CN100515390C (zh) * | 2005-04-14 | 2009-07-22 | 蔡海德 | 垂体前叶肾上腺皮质提取物纳米脂质体组合药物及其制备方法和用途 |
| US7446096B2 (en) * | 2005-12-19 | 2008-11-04 | Industrial Technology Research Institute | Glutathione based delivery system |
| US8067380B2 (en) * | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
-
2005
- 2005-12-19 US US11/303,934 patent/US7446096B2/en active Active
- 2005-12-27 JP JP2005374896A patent/JP4773200B2/ja active Active
- 2005-12-29 EP EP14180310.6A patent/EP2837384A1/en not_active Ceased
- 2005-12-29 SI SI200531880T patent/SI1891962T1/sl unknown
- 2005-12-29 PT PT52928207T patent/PT1891962E/pt unknown
- 2005-12-29 DK DK05292820.7T patent/DK1891962T3/da active
- 2005-12-29 PL PL05292820T patent/PL1891962T3/pl unknown
- 2005-12-29 ES ES05292820.7T patent/ES2516665T3/es active Active
- 2005-12-29 EP EP05292820.7A patent/EP1891962B1/en active Active
- 2005-12-30 TW TW094147661A patent/TWI365754B/zh active
-
2006
- 2006-01-19 CN CN2008101693581A patent/CN101385859B/zh active Active
- 2006-01-19 CN CN200610005869.0A patent/CN1985804B/zh active Active
-
2007
- 2007-12-11 US US12/000,261 patent/US7704956B2/en not_active Expired - Fee Related
-
2008
- 2008-11-03 US US12/263,885 patent/US7700564B2/en active Active
-
2010
- 2010-01-15 JP JP2010007125A patent/JP5394944B2/ja active Active
- 2010-03-11 US US12/721,633 patent/US8569239B2/en active Active
-
2014
- 2014-09-10 CY CY20141100728T patent/CY1115542T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101385859A (zh) | 2009-03-18 |
| CY1115542T1 (el) | 2017-01-04 |
| PT1891962E (pt) | 2014-11-11 |
| EP2837384A1 (en) | 2015-02-18 |
| US20100166849A1 (en) | 2010-07-01 |
| JP4773200B2 (ja) | 2011-09-14 |
| US20070141133A1 (en) | 2007-06-21 |
| SI1891962T1 (sl) | 2014-12-31 |
| TWI365754B (en) | 2012-06-11 |
| CN101385859B (zh) | 2011-12-07 |
| US7704956B2 (en) | 2010-04-27 |
| US7700564B2 (en) | 2010-04-20 |
| US20080095836A1 (en) | 2008-04-24 |
| US7446096B2 (en) | 2008-11-04 |
| JP2007169252A (ja) | 2007-07-05 |
| US20090060991A1 (en) | 2009-03-05 |
| US8569239B2 (en) | 2013-10-29 |
| CN1985804A (zh) | 2007-06-27 |
| JP2010150264A (ja) | 2010-07-08 |
| CN1985804B (zh) | 2014-05-14 |
| EP1891962B1 (en) | 2014-08-13 |
| JP5394944B2 (ja) | 2014-01-22 |
| EP1891962A1 (en) | 2008-02-27 |
| ES2516665T3 (es) | 2014-10-31 |
| DK1891962T3 (da) | 2014-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI365754B (en) | Glutathione based delivery system | |
| IL278979A (en) | Pharma-Informatics system | |
| HK1113657A1 (en) | Buccal delivery system | |
| IL184824A0 (en) | Infusion delivery system | |
| EP2061261A4 (en) | STEREO PROJECTION SYSTEM | |
| GB0517035D0 (en) | Delivery system | |
| EP1902360A4 (en) | SYSTEM FOR RELEASING CONTENT | |
| GB2432827B (en) | Fragrance delivery system | |
| ZA200804176B (en) | A delivery system | |
| EP1891801A4 (en) | DOCUMENT DISTRIBUTION SYSTEM | |
| GB2431563B (en) | Watersport hiking-support system | |
| GB0511518D0 (en) | Nofog system | |
| GB2433249B (en) | Pumping system | |
| GB0504771D0 (en) | System | |
| EP1857537A4 (en) | PUMPING SYSTEM FOR FLUIDS | |
| GB0518674D0 (en) | System | |
| GB2427760B (en) | Antenna-transceiver system | |
| GB0519069D0 (en) | Delivery system | |
| GB0525355D0 (en) | Delivery system | |
| ZA200610015B (en) | Nutrient delivery system | |
| GB2430017B (en) | Connection system | |
| AU2005902906A0 (en) | Delivery system | |
| AU2005905750A0 (en) | Delivery system | |
| PL114959U1 (en) | Delivery system | |
| GB0513683D0 (en) | Advanced parcel delivery system |